The Sinovac team has visited Indonesia to participate in monitoring the implementation of phase 3 clinical trials at health centers where the tests took place similar to what they have done in Turkey.
“Alhamdulillah (thanks be to God), the Sinovac team led by Senior Manager Yuansheng of the Clinical Department visited Indonesia, discussing the implementation of phase 3 clinical trials in Indonesia, and ensuring the safety and efficacy of the vaccine as well as the quality that meets the standards,” the president director said.
He also said that the volunteers who received shots from the vaccine’s clinical trial team have not reported any serious unwanted events or serious adverse events (SAE).
Regarding the news about the discontinuation of phase 3 clinical trials in Brazil after the discovery of an SAE incident on volunteers, Brazil’s National Health Surveillance Agency (Anvisa) confirmed that the incident was not related to the injection of the Covid-19 vaccine candidate. Therefore, in Brazil the phase 3 clinical trials for the Covid-19 vaccine candidate can be resumed, he added.
(Writer: Akhdi Martin Pratama | Editor: Ambaranie Nadia Kemala Movanita)https://t.me/kompascomupdate, kemudian join. Anda harus install aplikasi Telegram terlebih dulu di ponsel.